FDA approves under-the-tongue hay fever pill - Alabamas13.com WVTM-TV Birmingham, AL

FDA approves under-the-tongue hay fever pill

Updated: April 2, 2014 02:13 PM
© Keith Brofsky / Photodisc / Thinkstock © Keith Brofsky / Photodisc / Thinkstock
  • HealthMore>>

  • The 'Hobby Lobby ruling' and what it means for U.S. health care

    The 'Hobby Lobby ruling' and what it means for U.S. health care

    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
  • Diet changes can alter gut bacteria

    Diet changes can alter gut bacteria

    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
  • Lift U.S. ban on blood donations by gay men

    Lift U.S. ban on blood donations by gay men

    The United States should repeal a 30-year policy that bans blood donations from gay and bisexual men, according to a team of medical and legal experts writing this week in the Journal of the American Medical...
    The United States should repeal a 30-year policy that bans blood donations from gay and bisexual men, according to a team of medical and legal experts writing this week in the Journal of the American Medical Association.

WEDNESDAY, April 2, 2014 (HealthDay News) -- Just in time for the spring allergy season, the U.S. Food and Drug Administration on Wednesday approved a new under-the-tongue pill to treat hay fever caused by certain grass pollens.

Oralair is the first under-the-tongue allergen extract approved in the United States. The initial dose is taken in a doctor's office so that the patient can be monitored for any harmful reactions, and follow-up doses are taken at home.

"While there is no cure for grass pollen allergies, they can be managed through treatment and avoiding exposure to the pollen," Dr. Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research, said in an agency news release.

"The approval of Oralair provides an alternative to allergy shots that must be given in a health care provider's office," she added.

Patients begin taking the once-a-day tablet four months before the start of the grass pollen season and continue taking it for the duration of the season, the FDA said in a news release.

Oralair contains a combination of freeze-dried extracts from the pollens of five grasses: Kentucky Blue Grass, Orchard, Perennial Rye, Sweet Vernal and Timothy.

The tablet was tested in studies in Europe and the United States that involved a total of about 2,500 people. Those who took Oralair had a 16 percent to 30 percent drop in symptoms and the need for allergy medications, according to the FDA.

The most common side effects reported by patients taking the tablets were ear, mouth and tongue itching, swelling of the mouth and throat irritation. Oralair will carry a special "black box" warning on its label about the possibility of severe and possibly life-threatening allergic reactions.

According to the FDA, over 30 million Americans suffer from what's known as allergic rhinitis, often caused by a sensitivity to grass pollen. Symptoms include itchy or watery eyes, sneezing and nasal congestion.

Oralair is made by Stallergenes S.A. of France.

More information

The U.S. National Library of Medicine has more about hay fever.

Copyright © 2014 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow

1732 Valley View Dr.
Birmingham, AL 35209

Telephone: 205.933.1313
Fax: 205.323.3314
Email: newstips@alabamas13.com

Can't find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 Media General Communications Holdings, LLC. A Media General Company.